Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS

Cortical markers of L-DOPA-induced dyskinesias

Objective

Parkinson’s disease (PD) is a neurodegenerative disorder that affects about 1% of the population over 55. After more than 50 years, dopaminergic treatment is still the gold standard in PD therapy, although, as the disease progresses, several motor complications may arise. One of the most common and debilitating are known as L-DOPA-induced dyskinesias (LIDs), a condition that is observed in up to 80% of patients within five years of L-DOPA or dopaminergic agonists treatment. Although the exact neural mechanisms are still unclear, recent studies suggested that LIDs might be a consequence of an abnormal control of synaptic plasticity at cortico-striatal synapses. The target of this research project is to investigate the presence of cortical markers underlying the development of LIDs. This is a topic of critical relevance: if LIDs development would be predictable from previous cortical dysfunction, it will be possible to adjust the DA therapy, in terms of dose and duration, basing on the grade of LID risk. To this aim, we will use a novel multimodal approach consisting in combining different techniques of non-invasive brain stimulation with electroencephalography (EEG), electromyography (EMG), behavioral task and clinical evaluations. Specifically, the present project encompasses three studies that will investigate cortical dysfunctions at three levels: at a local level, by testing M1 reactivity and inhibitory circuits; at a network level, by testing M1 connectivity with the areas involved in LID development; and at a dynamic level, by testing M1 plasticity mechanisms. Two groups of PD patients, with and without LIDs, will be investigated and monitored with two clinical follow-ups to evaluate the presence/grade of LIDs. An age-matched group of healthy volunteers will be tested as control. The present project potentially have important clinical implications in understanding the cortical dysfunction underlying the development of LIDs.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.

You need to log in or register to use this function

Programme(s)

Multi-annual funding programmes that define the EU’s priorities for research and innovation.

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

MSCA-IF-EF-ST - Standard EF

See all projects funded under this funding scheme

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

(opens in new window) H2020-MSCA-IF-2017

See all projects funded under this call

Coordinator

UNIVERSITY COLLEGE LONDON
Net EU contribution

Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.

€ 183 454,80
Address
GOWER STREET
WC1E 6BT LONDON
United Kingdom

See on map

Region
London Inner London — West Camden and City of London
Activity type
Higher or Secondary Education Establishments
Links
Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

€ 183 454,80
My booklet 0 0